|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 2 of 41 found articles
| Title: |
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’ |
| Author: |
Schöffski, P. Wozniak, A. Stacchiotti, S. Rutkowski, P. Blay, J.-Y. Lindner, L.H. Strauss, S.J. Anthoney, A. Duffaud, F. Richter, S. Grünwald, V. Leahy, M.G. Reichardt, P. Sufliarsky, J. van der Graaf, W.T. Sciot, R. Debiec-Rychter, M. van Cann, T. Marréaud, S. Lia, M. Raveloarivahy, T. Collette, L. Bauer, S. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 28 () nr. 12 pages 3000-3008 |
| Year: |
2017 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 2 of 41 found articles
| << previous | next >> |